Stereotaxis, Inc.

For the period ended Sep 30, 2025. Filed Nov 12, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 12, 2025

STXS$1.14+4.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations

	Three Months Ended September 30,		Nine Months Ended September 30,
(in thousands, except share and per share amounts)	2025	2024	2025	2024
Revenue:
Systems	$1,861	$4,391	$6,863	$7,243
Disposables, service and accessories	5,603	4,805	16,872	13,335
Total revenue	7,464	9,196	23,735	20,578
Cost of revenue:
Systems	1,510	3,673	5,543	5,760
Disposables, service and accessories	1,853	1,424	5,448	3,440
Total cost of revenue	3,363	5,097	10,991	9,200
Gross margin	4,101	4,099	12,744	11,378
Operating expenses:
Research and development	2,546	2,454	6,673	6,970
Sales and marketing	2,934	3,152	9,351	9,456
General and administrative	5,178	4,838	13,675	12,064
Other	-	-	(492)	-
Total operating expenses	10,658	10,444	29,207	28,490
Operating loss	(6,557)	(6,345)	(16,463)	(17,112)
Other income	3	5	2	2
Interest income, net	91	150	349	580
Net loss	$(6,463)	$(6,190)	$(16,112)	$(16,530)
Cumulative dividend on convertible preferred stock	(322)	(328)	(953)	(984)
Net loss attributable to common stockholders	$(6,785)	$(6,518)	$(17,065)	$(17,514)
Net loss per share attributable to common stockholders:
Basic	$(0.07)	$(0.08)	$(0.19)	$(0.21)
Diluted	$(0.07)	$(0.08)	$(0.19)	$(0.21)
Weighted average number of common shares and equivalents:
Basic	92,013,791	85,824,789	89,260,628	84,629,531
Diluted	92,013,791	85,824,789	89,260,628	84,629,531

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.